RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

AstraZeneca Plc

A collection of news and information related to AstraZeneca Plc published by this site and its partners.

Top AstraZeneca Plc Articles see all

Displaying items 1-5
  • S&P 500 edges up to set new record; best month since Feb

    S&P 500 edges up to set new record; best month since Feb
    NEW YORK (Reuters) - U.S. stocks closed out a strong month on a quiet note on Friday, with the S&P 500 posting a modest gain to close at a new record as the latest positive data helped extend a rally that had been briefly threatened by overseas concerns.
  • AstraZeneca boosted by start of new cancer drug trial

    LONDON (Reuters) - Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer. The drug, which is designed to help the...

    Stock futures up, indexes on track for 4th week of gains

    Stock futures up, indexes on track for 4th week of gains
    NEW YORK (Reuters) - Stock index futures were modestly higher on Friday, suggesting the market's recent upswing was intact and pointing to a fourth straight week of gains for major indexes. * Stocks have been strong of late, with investors taking any...

    Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

    (Reuters) - Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S....

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...